Burkitt's lymphoma risk factors: Difference between revisions
Jump to navigation
Jump to search
Kamal Akbar (talk | contribs) No edit summary |
Kamal Akbar (talk | contribs) No edit summary |
||
Line 8: | Line 8: | ||
* [[HIV]]/[[AIDS]]<ref name="pmid29663523">{{cite journal| author=Meister A, Hentrich M, Wyen C, Hübel K| title=Malignant lymphoma in the HIV-positive patient. | journal=Eur J Haematol | year= 2018 | volume= 101 | issue= 1 | pages= 119-126 | pmid=29663523 | doi=10.1111/ejh.13082 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29663523 }} </ref> | * [[HIV]]/[[AIDS]]<ref name="pmid29663523">{{cite journal| author=Meister A, Hentrich M, Wyen C, Hübel K| title=Malignant lymphoma in the HIV-positive patient. | journal=Eur J Haematol | year= 2018 | volume= 101 | issue= 1 | pages= 119-126 | pmid=29663523 | doi=10.1111/ejh.13082 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29663523 }} </ref> | ||
* Post-transplant immunosuppression | * Post-transplant immunosuppression | ||
* Malaria<ref name="pmid29676453">{{cite journal| author=Karimi P, Birmann BM, Anderson LA, McShane CM, Gadalla SM, Sampson JN et al.| title=Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink. | journal=Br J Haematol | year= 2018 | volume= 181 | issue= 4 | pages= 505-514 | pmid=29676453 | doi=10.1111/bjh.15229 | pmc=5980720 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29676453 }} </ref> | * [[Malaria]]<ref name="pmid29676453">{{cite journal| author=Karimi P, Birmann BM, Anderson LA, McShane CM, Gadalla SM, Sampson JN et al.| title=Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink. | journal=Br J Haematol | year= 2018 | volume= 181 | issue= 4 | pages= 505-514 | pmid=29676453 | doi=10.1111/bjh.15229 | pmc=5980720 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29676453 }} </ref> | ||
==References== | ==References== |
Revision as of 16:04, 28 December 2018
Burkitt's lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Burkitt's lymphoma risk factors On the Web |
American Roentgen Ray Society Images of Burkitt's lymphoma risk factors |
Risk calculators and risk factors for Burkitt's lymphoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Common risk factors in the development of Burkitt's lymphoma may be HIV/AIDS and post-transplant immunosuppression. There are no risk factors for childhood Burkitt's lymphoma.
Risk Factors
Common risk factors in the development of Burkitt's lymphoma may include:[1]
References
- ↑ 1.0 1.1 Karimi P, Birmann BM, Anderson LA, McShane CM, Gadalla SM, Sampson JN; et al. (2018). "Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink". Br J Haematol. 181 (4): 505–514. doi:10.1111/bjh.15229. PMC 5980720. PMID 29676453.
- ↑ Meister A, Hentrich M, Wyen C, Hübel K (2018). "Malignant lymphoma in the HIV-positive patient". Eur J Haematol. 101 (1): 119–126. doi:10.1111/ejh.13082. PMID 29663523.